title: Induction of secretory immunity with bioadhesive poly (D,L-lactide-co-glycolide) microparticles containing Streptococcus sobrinus glucosyltransferase.
abstract: The effect of mucosal delivery of Streptococcus sobrinus glucosyltransferase (GTF) in bioadhesive poly (D,L-lactide-co-glycolide) (PLGA) microparticles on induction of salivary IgA and serum IgG antibody responses was measured in Sprague-Dawley rats. Preparations of GTF/PLGA/gelatin microparticles, or PLGA/gelatin microparticles or GTF in alum, were administered four times at weekly intervals by intranasal or intragastric routes. Two subcutaneous injections of GTF in PLGA/gelatin microparticles or in alum were given to separate groups of rats. Significant elevations in salivary IgA antibody levels to S. sobrinus GTF were observed only in the groups immunized intranasally 28 days after immunizations were begun. Five of six rats given the GTF microparticles intranasally had positive salivary IgA antibody responses to GTF, and the mean salivary IgA antibody level of this group was 30-fold higher than any other mucosally or systemically immunized group. Salivary IgA responses in the GTF-microparticle group remained significantly higher than all other mucosally immunized groups for at least 10 weeks after the primary immunization. All rats in this group demonstrated aspects of anamnesis following a more limited secondary course of intranasal administration. Intranasal administration of GTF in microparticles also induced a serum IgG response to GTF in some rats. After secondary intranasal GTF microparticle administration, several rats had sustained serum IgG antibody levels that were within the range of sera from rats subcutaneously injected with GTF in microparticles or in alum. Thus intranasal delivery of GTF-containing bioadhesive microparticles induced the highest and longest lasting salivary immune response of any mucosal or systemic route or vehicle tested and could be expected to be a useful method for induction of mucosal immunity.
authors.affiliation: Department of Immunology, Forsyth Dental Center, 140 The Fenway, Boston, MA 02115, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: Smith
authors.forename: D J
authors.initials: DJ
authors.lastname: Trantolo
authors.forename: W F
authors.initials: WF
authors.lastname: King
authors.forename: E J
authors.initials: EJ
authors.lastname: Gusek
authors.forename: P H
authors.initials: PH
authors.lastname: Fackler
authors.forename: J D
authors.initials: JD
authors.lastname: Gresser
authors.forename: V L
authors.initials: VL
authors.lastname: De Souza
authors.forename: D L
authors.initials: DL
authors.lastname: Wise
mesh_terms: D000281:Administration, Intranasal; D000534:Alum Compounds; D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis* / Q000097:blood; D005780:Gelatin / Q000276:immunology; D005964:Glucosyltransferases / Q000008:administration & dosage / Q000276:immunology*; D018928:Immunity, Mucosal; D007117:Immunization, Secondary; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000097:blood; D019344:Lactic Acid / Q000276:immunology*; D011100:Polyglycolic Acid; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers; D051381:Rats; D017207:Rats, Sprague-Dawley; D012463:Saliva / Q000276:immunology*; D016986:Streptococcus sobrinus / Q000276:immunology*; D013997:Time Factors; D014611:Vaccination
chemical_list: D000534:Alum Compounds; D000907:Antibodies, Bacterial; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D011108:Polymers; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; D005780:Gelatin; D005964:Glucosyltransferases